A protocol avoiding allogeneic transfusion in joint arthroplasties
- 923 Downloads
Arthroplasties of hip and knee are associated with blood loss, which may lead to adverse patient outcome. Performing arthroplasties in Jehovah’s Witness patients who do not accept transfusion has been a matter of concern. We developed a protocol, which avoids transfusion in arthroplasties of Jehovah’s Witness patients, and evaluated the feasibility and safety of the protocol.
Materials and methods
The target of preoperative hemoglobin was more than 10 g/dL. When preoperative hemoglobin was lower than 10 g/dL, 4000 U erythropoietin (3 times a week) and 100 mg iron supplement (every day) were administered until the hemoglobin reached 10 g/dL. When the preoperative hemoglobin was higher than 10 g/dL, 4000 U erythropoietin and 100 mg iron supplement were administered once, before operation. During the operation, cell saver was used. Postoperatively, erythropoietin and iron supplements were administered until the hemoglobin reached 10 g/dL, similar to the preoperative protocol. We evaluated the feasibility of our protocol, perioperative complications and hematologic changes.
From 2002 to 2014, 186 Witness patients visited our department. In 179 patients (96.2 %), 77 total knee arthroplasties, 69 bipolar hemiarthroplasties and 33 total hip arthroplasties were performed. The mean hemoglobin level was 12.3 g/dL preoperatively, 9.4 g/dL on postoperative day 3 and 10.3 g/dL on postoperative day 7. One patient died immediately after the arthroplasty and the remaining 178 patients survived.
Total joint arthroplasty could be done without transfusion using this protocol in most of our patients. The rates of infection and mortality were similar with known infection and mortality rates of arthroplasties. In patients who do not want allogeneic transfusions, our protocol is a safe alternative to perform joint arthroplasties.
KeywordsTransfusion Arthroplasty Hip Knee
This work was supported by the Soonchunhyang University Research Fund.
Compliance with ethical standards
Conflict of interest
No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
- 1.Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, Attarian DE, Grant SA, Green CL, Vail TP, Bolognesi MP (2014) Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Jt Surg Am 96(4):279–284. doi: 10.2106/JBJS.L.01041 CrossRefGoogle Scholar
- 4.Shemshaki H, Nourian SM, Nourian N, Dehghani M, Mokhtari M, Mazoochian F (2015) One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration. Arch Orthop Trauma Surg 135(4):573–588. doi: 10.1007/s00402-015-2189-7 CrossRefPubMedGoogle Scholar
- 11.Aguilera X, Martinez-Zapata MJ, Hinarejos P, Jordan M, Leal J, Gonzalez JC, Monllau JC, Celaya F, Rodriguez-Arias A, Fernandez JA, Pelfort X, Puig-Verdie L (2015) Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch Orthop Trauma Surg 135(7):1017–1025. doi: 10.1007/s00402-015-2232-8 CrossRefPubMedGoogle Scholar
- 18.de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC (1996) Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop (Belle Mead NJ) 25(8):533–542Google Scholar
- 25.Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Jt Surg Am 81(1):2–10Google Scholar
- 28.Borghi B, Pignotti E, Montebugnoli M, Bassi A, Corbascio M, de Simone N, Elmar K, Righi U, Laguardia AM, Bugamelli S, Cataldi F, Ranocchi R, Feoli MA, Bombardini T, Gargioni G, Franchini AG, Caroli GC (1997) Autotransfusion in major orthopaedic surgery: experience with 1785 patients. Br J Anaesth 79(5):662–664CrossRefPubMedGoogle Scholar
- 32.Nelson CL, Bowen WS (1986) Total hip arthroplasty in Jehovah’s Witnesses without blood transfusion. J Bone Jt Surg Am 68(3):350–353Google Scholar
- 36.Lotke PA, Faralli VJ, Orenstein EM, Ecker ML (1991) Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion. J Bone Jt Surg Am 73(7):1037–1040Google Scholar
- 39.Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H (1999) The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Jt Surg Am 81(11):1580–1588Google Scholar
- 50.Konishi A, Kikuchi A (1996) Advertisement of bloodless medicine: the role of the department of anesthesiology. Autotransfusion 9:17–19Google Scholar
- 51.Morais S, Ortega-Andreu M, Rodriguez-Merchan EC, Padilla-Eguiluz NG, Perez-Chrzanowska H, Figueredo-Zalve R, Gomez-Barrena E (2014) Blood transfusion after primary total knee arthroplasty can be significantly minimised through a multimodal blood-loss prevention approach. Int Orthop 38(2):347–354. doi: 10.1007/s00264-013-2188-7 CrossRefPubMedGoogle Scholar
- 52.Horstmann WG, Swierstra MJ, Ohanis D, Rolink R, Kollen BJ, Verheyen CC (2014) Favourable results of a new intraoperative and postoperative filtered autologous blood re-transfusion system in total hip arthroplasty: a randomised controlled trial. Int Orthop 38(1):13–18. doi: 10.1007/s00264-013-2084-1 CrossRefPubMedGoogle Scholar
- 62.Moonen AF, Thomassen BJ, Knoors NT, van Os JJ, Verburg AD, Pilot P (2008) Pre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial. J Bone Jt Surg Br 90(8):1079–1083. doi: 10.1302/0301-620X.90B8.20595 CrossRefGoogle Scholar
- 67.Weber EW, Slappendel R, Hemon Y, Mahler S, Dalen T, Rouwet E, van Os J, Vosmaer A, van der Ark P (2005) Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 22(4):249–257CrossRefPubMedGoogle Scholar
- 68.Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T (2004) Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo. J Bone Jt Surg Br 86(1):31–33Google Scholar
- 70.Munoz M, Gomez-Ramirez S, Cuenca J, Garcia-Erce JA, Iglesias-Aparicio D, Haman-Alcober S, Ariza D, Naveira E (2014) Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 54(2):289–299. doi: 10.1111/trf.12195 PubMedGoogle Scholar
- 72.Enko D, Wallner F, von-Goedecke A, Hirschmugl C, Auersperg V, Halwachs-Baumann G (2013) The impact of an algorithm-guided management of preoperative anemia in perioperative hemoglobin level and transfusion of major orthopedic surgery patients. Anemia 2013:641876. doi: 10.1155/2013/641876 CrossRefPubMedPubMedCentralGoogle Scholar
- 75.Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH (2011) Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 51(1):118–124. doi: 10.1111/j.1537-2995.2010.02783.x CrossRefPubMedGoogle Scholar
- 76.Cuenca J, Garcia-Erce JA, Martinez F, Perez-Serrano L, Herrera A, Munoz M (2006) Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 46(7):1112–1119. doi: 10.1111/j.1537-2995.2006.00859.x CrossRefPubMedGoogle Scholar
- 77.Cuenca J, Garcia-Erce JA, Martinez AA, Solano VM, Molina J, Munoz M (2005) Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch Orthop Trauma Surg 125(5):342–347. doi: 10.1007/s00402-005-0809-3 CrossRefPubMedGoogle Scholar